We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evo... Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202. Show more
WINTER PARK, Fla., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that it will report its financial and operating results for...
WINTER PARK, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”), an owner and operator of single tenant net leased commercial...
WINTER PARK, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that its Board of Directors has authorized, and the Company...
WINTER PARK, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”) today announced that Jeffrey S. Yarckin has notified the Company of...
WINTER PARK, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”), an owner and operator of single tenant net leased commercial...
WINTER PARK, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced the origination of a $40.2 million first mortgage loan with an...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.135 | -0.79341757273 | 17.015 | 17.0793 | 16.06 | 124540 | 16.44463776 | CS |
4 | 0.54 | 3.30477356181 | 16.34 | 17.19 | 16.06 | 87834 | 16.70282038 | CS |
12 | -0.81 | -4.57885811193 | 17.69 | 18.46 | 16.06 | 93076 | 17.26091965 | CS |
26 | -0.38 | -2.20162224797 | 17.26 | 19.42 | 16.06 | 82977 | 17.63935114 | CS |
52 | 0.91 | 5.69818409518 | 15.97 | 19.42 | 14.325 | 65991 | 16.83720932 | CS |
156 | -2.61 | -13.3914828117 | 19.49 | 20.7899 | 14.25 | 70155 | 17.22737275 | CS |
260 | -1.78 | -9.53912111468 | 18.66 | 21.069 | 7.56 | 69375 | 17.04180428 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions